Select Medical Holdings Corporation provided earnings guidance for the year 2024. For the year, the company expected revenue to be in the range of $6.9 billion to $7.1 billion and fully diluted earnings per share to be in the range of $1.88 to $2.18.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.59 USD | +1.08% | +6.87% | +42.94% |
05-06 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
05-06 | Benchmark Adjusts Price Target on Select Medical Holdings to $42 From $39, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.94% | 4.32B | |
+20.68% | 84.31B | |
-29.31% | 69.9B | |
+9.65% | 29.06B | |
-8.63% | 17.38B | |
+2.14% | 17.01B | |
+0.39% | 15.35B | |
+6.47% | 12.91B | |
+68.23% | 12.47B | |
+6.43% | 12.26B |
- Stock Market
- Equities
- SEM Stock
- News Select Medical Holdings Corporation
- Select Medical Holdings Corporation Provides Earnings Guidance for the Year 2024